194 related articles for article (PubMed ID: 14671964)
21. Treatment of Fetal Cystic Fibrosis With Cystic Fibrosis Transmembrane Conductance Regulator Modulation Therapy.
Blumenfeld YJ; Hintz SR; Aziz N; Barth RA; Spano JM; El-Sayed YY; Milla C
Ann Intern Med; 2023 Jul; 176(7):1015-1016. PubMed ID: 37307583
[No Abstract] [Full Text] [Related]
22. Cholangiocyte biology and cystic fibrosis liver disease.
Feranchak AP; Sokol RJ
Semin Liver Dis; 2001 Nov; 21(4):471-88. PubMed ID: 11745036
[TBL] [Abstract][Full Text] [Related]
23. [The relationship between cystic fibrosis and bronchiectasis and its research implications in Chinese].
Li HP; He GJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):627-9. PubMed ID: 15498278
[No Abstract] [Full Text] [Related]
24. Hepatobiliary disease in children and adolescents with cystic fibrosis.
Nascimento FS; Sena NA; Ferreira TDA; Marques CDF; Silva LR; Souza EL
J Pediatr (Rio J); 2018; 94(5):504-510. PubMed ID: 28888897
[TBL] [Abstract][Full Text] [Related]
25. Does the mutation of the SERPINA1 gene contribute to liver damage and cholestasis in patients with diagnosed cystic fibrosis? preliminary study.
Więcek S; Woś H; Kordys-Darmolińska B; Sankiewicz-Szkółka M; Grzybowska-Chlebowczyk U
Dev Period Med; 2015; 19(1):92-7. PubMed ID: 26003074
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis.
Hubert D; Fajac I; Bienvenu T; Desmazes-Dufeu N; Ellaffi M; Dall'Ava-Santucci J; Dusser D
J Cyst Fibros; 2004 Aug; 3(3):203. PubMed ID: 15463911
[No Abstract] [Full Text] [Related]
27. Patterns of GI disease in adulthood associated with mutations in the CFTR gene.
Wilschanski M; Durie PR
Gut; 2007 Aug; 56(8):1153-63. PubMed ID: 17446304
[No Abstract] [Full Text] [Related]
28. Liver and biliary problems in cystic fibrosis.
Colombo C; Battezzati PM; Strazzabosco M; Podda M
Semin Liver Dis; 1998; 18(3):227-35. PubMed ID: 9773423
[TBL] [Abstract][Full Text] [Related]
29. Novel de novo large deletion in cystic fibrosis transmembrane conductance regulator gene results in a severe cystic fibrosis phenotype.
Norek A; Stremska M; Sobczyńska-Tomaszewska A; Wertheim-Tysarowska K; Dmeńska H; Jurek M
J Pediatr; 2011 Aug; 159(2):343-6.e1. PubMed ID: 21663921
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis.
Sathe MN; Freeman AJ
Pediatr Clin North Am; 2016 Aug; 63(4):679-98. PubMed ID: 27469182
[TBL] [Abstract][Full Text] [Related]
31. Mild course of cystic fibrosis in an adult with the D1152H mutation.
Feldmann D; Rochemaure J; Plouvier E; Magnier C; Chauve C; Aymard P
Clin Chem; 1995 Nov; 41(11):1675. PubMed ID: 7586569
[No Abstract] [Full Text] [Related]
32. Pancreatitis and mutations of the cystic fibrosis gene.
Durie PR
N Engl J Med; 1998 Sep; 339(10):687-8. PubMed ID: 9725928
[No Abstract] [Full Text] [Related]
33. Idiopathic CD4+ T lymphocytopenia presenting as mycetoma in a patient with a mutation in the cystic fibrosis transmembrane regulator gene.
Zollner TM; Stracke S; Neumeister B; Manfras B; Boehncke W; Boehm BO; Marre R; Sterry W
Arch Dermatol; 1996 Oct; 132(10):1247-9. PubMed ID: 8859043
[No Abstract] [Full Text] [Related]
34. Cystic fibrosis and congenital pancreatic insufficiency.
Alaswad B; Rose VM
J Pediatr Gastroenterol Nutr; 1999 Jul; 29(1):108. PubMed ID: 10400120
[No Abstract] [Full Text] [Related]
35. Origins of growth deficiencies in cystic fibrosis.
Le TN; Schechter MS
Thorax; 2019 May; 74(5):423-424. PubMed ID: 30798253
[No Abstract] [Full Text] [Related]
36. Liver disease in cystic fibrosis.
Tanner MS; Taylor CJ
Arch Dis Child; 1995 Apr; 72(4):281-4. PubMed ID: 7539244
[No Abstract] [Full Text] [Related]
37. Cystic fibrosis liver disease in children - A review of our current understanding.
Costaguta G; Patey N; Álvarez F
Arch Argent Pediatr; 2023 Aug; 121(4):e202202905. PubMed ID: 36856762
[TBL] [Abstract][Full Text] [Related]
38. Cystic fibrosis and atopy.
Rosario NA; Riedi CA
Allergol Immunopathol (Madr); 2013; 41(2):137-9. PubMed ID: 23265269
[No Abstract] [Full Text] [Related]
39. Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this cystic fibrosis transmembrane conductance regulator mutation does not cause cystic fibrosis.
Derichs N; Schuster A; Grund I; Ernsting A; Stolpe C; Körtge-Jung S; Gallati S; Stuhrmann M; Kozlowski P; Ballmann M
Clin Genet; 2005 Jun; 67(6):529-31. PubMed ID: 15857421
[No Abstract] [Full Text] [Related]
40. [Cystic fibrosis: current therapy. Diagnosis and treatment of hepatobiliary diseases].
Spalinger J
Schweiz Med Wochenschr Suppl; 2000; 122():17S-21S. PubMed ID: 12536465
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
